Search Results - "Kramchaninov, Mikhail M"
-
1
Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation
Published in Case reports in oncology (01-05-2019)“…Vemurafenib has been developed to target common BRAF mutation V600E. It also exerts activity towards some but not all rare BRAF substitutions. Proper…”
Get full text
Journal Article -
2
Comparison of the treatment results in patients with inoperable non-small cell lung cancer in clinical trials and in standard clinical practice using the pseudorandomization method
Published in Alʹmanakh klinicheskoĭ medit͡s︡iny (28-04-2022)“…Rationale: Non-small cell lung cancer (NSCLC) is an aggressive disease with median survival of 1214 months in inoperable patients in the pre-immunotherapy era…”
Get full text
Journal Article -
3
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients
Published in Clinical drug investigation (01-06-2018)“…Background Colorectal carcinomas (CRCs) are sensitive to treatment by anti-epidermal growth factor receptor (EGFR) antibodies only if they do not carry…”
Get full text
Journal Article -
4
Efficacy of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim results of observational prospective study
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
5
Observational study of the efficacy of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim analysis
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e14593 Background: Therapy with immune checkpoint inhibitors (ICI) changed the paradigm of treatment in many solid tumors including NSCLC…”
Get full text
Journal Article -
6
Сonfirmatory study of the efficacy and tolerability of trifluridine/tipiracil (TAS-102) therapy in the Russian population with chemorefractory metastatic colorectal cancer
Published in Medicinskij sovet (21-12-2020)“…Introduction. Trifluridine/Tipiracil (FTD/TPI) is a new chemotherapeutic drug approved in more than 60 countries for use in patients with metastatic colorectal…”
Get full text
Journal Article -
7
Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation
Published in Case reports in oncology (01-05-2019)Get full text
Report